跳至主要内容
临床试验/NCT00443274
NCT00443274进行中(未招募)不适用

Breast Implant Follow-up Study: A Long-term Observational Study of the Safety of Allergan Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms (410-arm)

Allergan1 个研究点 分布在 1 个国家目标入组 56,460 人开始时间: 2006年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Allergan
入组人数
56,460
试验地点
1
主要终点
Risk rates of common complications of breast surgery (eg, capsular contracture, implant rupture/deflation) assessed by the subject and investigator

研究概览

简要总结

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Screening Criteria
  • age 18 years or older who is a candidate for breast reconstruction (primary or revision) with Allergan silicone implants or saline breast implants (controls) OR
  • age 22 or older who is a candidate for breast augmentation (primary or revision) with Allergan silicone implants or saline breast implants (controls)
  • Exhibit fluency and literacy in English or Spanish
  • Enrollment Criteria
  • Have satisfied all the inclusion and none of the exclusion criteria
  • Have completed the implant surgery
  • Have only one breast implant or have matching breast implants (i.e., both Round Responsive, both Style 410, or both saline) following their qualifying surgery. In the case of silicone, the device(s) must be manufactured by Allergan.
  • Are free of all target diseases at baseline (410 arm only)
  • Have signed the informed consent form, documenting agreement to participate in all required follow-up interviews by internet, phone, or mail and authorizing health care providers to release medical records to study personnel, and have completed the baseline questionnaire prior to implant surgery (prospectively enrolled subjects)
  • For retrospectively enrolled subjects into the 410 arm, in addition to the above, these criteria also apply:
  • Received 1 or 2 Style 410 implants between 2015 and 2019
  • Willing to complete baseline questionnaire at time of enrollment
  • Continuation Criteria (BIFS Arm Only)
  • Have completed baseline and years 1, 2, 3 and 4 follow-up questionnaires available (including the Satisfaction with Breasts and Psychosocial Well-Being modules of the BREAST-Q)
  • Met all enrollment criteria, specifically the minimum age requirements for silicone implants (18 or older for reconstruction subjects and 22 or older for augmentation subjects), and were free of all target diseases at baseline
  • Were enrolled at a site that was selected in the cluster sampling to continue in the BIFS arm

排除标准

  • Are transgender
  • If a saline implant subject, have a current or past unilateral or bilateral silicone gelfilled breast implant
  • Investigator decision that subject is not a suitable candidate for a long-term observational study

结局指标

主要结局

Risk rates of common complications of breast surgery (eg, capsular contracture, implant rupture/deflation) assessed by the subject and investigator

时间窗: 10 Years

Risk rates of adverse events of high clinical interest (eg, cancers, neurological diseases, connective tissue diseases) assessed by the investigator

时间窗: 10 Years

Re-operations

时间窗: 10 Years

Rates of reoperation reported by subjects and by investigators at office visits

次要结局

未报告次要终点

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验